BIO
Bio-Rad Laboratories, Inc. · Healthcare · Medical - Devices
Momentum-Eingaben (vergleichbare Manager):
Halterbreite -5.9% ·
Aktienfluss -4.1% ·
neue Nettopositionen -6.2%
· Formel
Breite Distribution: sinkende Aktienanzahl und weniger Inhaber
Alle Eigentumszahlen: nur beobachtete 13F-Manager, Stammaktienpositionen, Berichtszeitraum Q2 2025
| Quartal | Inhaber | Δ | Aktien | Gemeldeter Wert | Neu | Ausstiege |
|---|---|---|---|---|---|---|
| Q3 2026 | 2 | 0 | 149.14K | $56.30M | n/a | n/a |
| Q2 2026 | 114 | -3 | 11.65M | $3.42B | +7 | −12 |
| Q1 2026 | 122 | +9 | 14.35M | $4.00B | +14 | −6 |
| Q4 2025 | 113 | -3 | 13.80M | $4.16B | +1 | −3 |
| Q3 2025 | 20 | +2 | 5.24M | $1.47B | +2 | −1 |
| Q2 2025 | 16 | -1 | 5.26M | $1.27B | +1 | −2 |
| Q1 2025 | 14 | -2 | 1.87M | $455.90M | n/a | −2 |
| Q4 2024 | 16 | +1 | 2.05M | $672.31M | +1 | n/a |
| Q3 2024 | 14 | +2 | 1.60M | $536.26M | +3 | −1 |
| Q2 2024 | 12 | n/a | 1.03M | $281.62M | n/a | n/a |
| # | Manager | Aktien | Δ Anteile | Wert | Deren Gewichtung | Gehalten | ||
|---|---|---|---|---|---|---|---|---|
| 1 | The Vanguard Group ✦ (passiv) | 1.85M | n/a | $445.61M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 2 | BlackRock ✦ (passiv) | 1.76M | n/a | $425.36M | 0.0% | n/c | 1 | SEC ↗ ×18 |
| 3 | State Street Global Advisors ✦ (passiv) | 584.37K | -15.9% | $141.02M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 4 | Geode Capital Management ✦ (passiv) | 334.14K | -2.6% | $80.65M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 5 | Millennium Management ✦ | 251.85K | -25.1% | $60.78M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 6 | Fisher Asset Management ✦ | 137.74K | -4.1% | $33.24M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 7 | Norges Bank ✦ (passiv) | 128.41K | -18.1% | $30.99M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 8 | Gotham Asset Management ✦ | 87.86K | +208.7% | $21.20M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 9 | T. Rowe Price ✦ | 36.82K | +24.9% | $8.89M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 10 | AQR Capital Management ✦ | 28.19K | +51.7% | $6.80M | 0.0% | ▲ Add | 5 | SEC ↗ ×3 |
| 11 | GAMCO Investors ✦ | 26.75K | 0.0% | $6.46M | 0.1% | Held | 5 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 23.98K | Neu | $5.79M | 0.0% | New | 1 | SEC ↗ |
| 13 | D. E. Shaw & Co. ✦ | 3.30K | -82.6% | $796,356 | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 14 | Citadel Advisors ✦ | 2.62K | -79.6% | $631,776 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 15 | Fidelity (FMR) ✦ | 2.28K | n/a | $549,226 | 0.0% | n/c | 1 | SEC ↗ ×3 |
| 16 | Marshall Wace ✦ | 926 | -96.6% | $223,462 | 0.0% | ▼ Trim | 3 | SEC ↗ |
„Ihr Gewicht" = Anteil der Position am gemeldeten 13F-Aktienwert des Managers: das Überzeugungsmaß. ✦ = kuratorisch betreuter Manager.
Neue Käufer
| Arrowstreet Capital | $5.79M | 0.0% |
Ausgestiegen
| Point72 Asset Management | $8.43M | war 0.0% |
| Wellington Management | $574,558 | war 0.0% |
Marktweiter Kontext: über ALLE 13F-Melder (strukturierte SEC-Daten, Q1 2026): 387 Inhaber, 19.87M Anteile, $5.29B gemeldet. Dies ist ein anderer, älterer Zeitraum als die oben genannten Zahlen des erfassten Universums; beide werden niemals vermischt.
Was die erfassten Halter dieses Wertpapiers am häufigsten sonst noch halten: gemeinsame Eigentümerzahlen, keine fundamentalen Beziehungen.